HealthEquity vs Priority Technology
HQY and PRTH side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HQY and PRTH compare
HealthEquity is the larger company, worth 13 times as much as Priority Technology ($8.5B against $646M).
On earnings, Priority Technology is cheaper: it trades at 11.4× trailing earnings, against 37.0× for HealthEquity.
Priority Technology grew revenue faster over the last twelve months (8.9% versus 7.3% for HealthEquity).
HealthEquity scores higher on the StockData Score (15 against 8 for Priority Technology), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HQY | PRTH |
|---|---|---|
| Size and price | ||
| Market cap | $8.5B | $646M |
| Share price | $102.47 | $7.84 |
| Change, 1 year | 8.5% | 10.0% |
| Change, 5 years | 50.2% | 25.6% |
| Beta (5Y) | 0.39 | 1.01 |
| Employees | 2,814 | 1,200 |
| StockData Score | ||
| Total score | 15 (better) | 8 |
| Valuation score | 3 | 4 (better) |
| Growth score | 3 (better) | 2 |
| Performance score | 4 (better) | 1 |
| Health score | 5 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 37.0× | 11.4× (better) |
| P/S | 6.2× | 0.6× (better) |
| P/B | 4.3× | – |
| EV/EBITDA | 18.0× | 7.5× (better) |
| P/FCF | 17.4× | 6.2× (better) |
| FCF yield | 5.8% | 16.0% (better) |
| Fair value | $109.86 | $16.10 |
| Margin of safety | 6.7% | 51.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 7.3% | 8.9% (better) |
| Revenue growth, 5Y average | 12.4% | 18.7% (better) |
| Net income growth (TTM) | 62.2% | – |
| EPS growth (TTM) | 67.9% | 165% (better) |
| EPS growth, 5Y average | 83.0% (better) | 12.3% |
| Profitability | ||
| Gross margin | 71.2% (better) | 39.4% |
| Operating margin | 25.8% (better) | 13.8% |
| Net margin | 17.4% | – |
| FCF margin | 35.8% (better) | 10.4% |
| Return on equity | 11.4% | – |
| Return on invested capital | 9.8% | 13.8% (better) |
| Financial health | ||
| Debt / equity | 0.47 | – |
| Net debt / EBITDA | 1.33 (better) | 4.38 |
| Interest coverage | 6.7× (better) | 1.6× |
| Current ratio | 2.99 (better) | 1.10 |
| Altman Z-score | 4.92 (better) | 0.77 |
| Piotroski F-score | 9 | – |
| Dividends and buybacks | ||
| Buyback yield | 4.8% | – |
| Shareholder yield | 4.8% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 109% | 23.6% |
| Held by insiders | 1.7% | 59.6% |
| Insider net buying, 12 months | −$4.2M | −$23.8K (better) |
| Short interest, % of float | 7.4% | – |
Go deeper
- HQY stock overview
- HQY income statement
- HQY valuation and score
- PRTH stock overview
- PRTH income statement
- PRTH valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.